These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6826225)

  • 1. Increased vascular sensitivity to angiotensin ii in psychosocial hypertensive mice.
    Webb RC; Johnson JC; Vander AJ; Henry JP
    Hypertension; 1983; 5(2 Pt 2):I165-9. PubMed ID: 6826225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
    Bianchetti MG; Weidmann P; Beretta-Piccoli C; Ferrier C
    Kidney Int; 1987 Apr; 31(4):956-63. PubMed ID: 3586502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.
    Dubinion JH; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.
    Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney.
    De Mey C; Vanhoutte PM
    Hypertension; 1981; 3(6):718-24. PubMed ID: 7298125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
    Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
    Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vasodilator responses to acetylcholine in psychosocial hypertensive mice.
    Webb RC; Vander AJ; Henry JP
    Hypertension; 1987 Mar; 9(3):268-76. PubMed ID: 3028955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension.
    Imig JD
    Am J Hypertens; 2000 Jul; 13(7):810-8. PubMed ID: 10933574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.
    Beretta-Piccoli C; Weidmann P
    Am J Med; 1981 Nov; 71(5):829-35. PubMed ID: 7304655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of vascular hyperresponsiveness in the spontaneously hypertensive rat.
    Lais LT; Brody MJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):216-22. PubMed ID: 1132081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral factor in pressor hyperresponsiveness in renal prehypertensive rabbits.
    Johnson JA; Kurz KD; Siripaisarnpipat S; Koivunen DG; Zeigler DW; Sakamaki T; Payne CG
    Hypertension; 1983; 5(4):453-9. PubMed ID: 6345358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.